Inventor

COX JASON M

US31 patents

⚠️ This page may combine multiple inventors who share the name “COX JASON M”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

COX JASON M

MERCK SHARP & DOHME

2-amino-n-heteroaryl-nicotinamides as Nav1.8 inhibitors

Substituted pyrazolo[3,4-d]pyrimidines as PDE9 inhibitors

Substituted pyrazolo[3,4-d]pyrimidines as PDE9 inhibitors

Fused aminopiperidines as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes

Aminopiperidines as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes

Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes

2-oxoimidazolidine-4-carboxamides as NAv1.8 inhibitors

Substituted tetrahydroisoquinoline compounds useful as GPR120 agonists

Fused aminopiperidines as dipeptidyi peptidase-IV inhibitors for the treatment or prevention of diabetes

Fused aminopiperidines as dipeptidyl peptidase-4 inhibitors for the treatment or prevention of diabetes

Tricyclic heteroaromatic compounds as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes

Hydroxy isoxazole compounds useful as GPR120 agonists

Mineralocorticoid receptor antagonists

Substituted spiropiperidinyl compounds useful as GPR120 agonists

KINNATE BIOPHARMA INC

Inhibitors of fibroblast growth factor receptor kinases

Inhibitors of MEK kinase

Inhibitors of MEK kinase

Inhibtors of Raf kinases

Inhibitors of MET kinase

MERCK SHARP & DOHME LLC

2-amino-N-heteroaryl-nicotinamides as Nav1.8 inhibitors

Cyclobutyl pyrazolopyrimidine PDE9 inhibitors

4-amino or 4-alkoxy-substituted aryl sulfonamide compounds with selective activity in voltage-gated sodium channels

BIFTU TESFAYE

Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes

Heterocyclic compounds as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes

BUTLER EUGENE W

Differential excitation spectroscopy

Differential excitation spectroscopy II

SHEN HONG

Mineralocorticoid receptor antagonists

Mineralocorticoid receptor antagonists

KHORA SPV 1 LLC

Inhibitors of fibroblast growth factor receptor kinases

CELYN THERAPEUTICS INC

Inhibitors of MET kinase

COX JASON M

Substituted aminopiperidines as dipeptidyl peptidase-IV inhibitors for the treatment of diabetes